Moscow, June, 18 2006 Quantum Pharmaceuticals and Federal State Institution "Scientific Research Institute of Pulmonology of Roszdrav" entered COPD collaboration.
Quantum Pharmaceuticals and Federal State Institution "Scientific Research Institute of Pulmonology of Roszdrav» announced drug discovery collaboration. The collaboration is aimed on the application of Quantum Pharmaceuticals’ proprietary drug discovery technology to identify novel small molecules inhibitors of Human Neutrophil Elastase.
Under the terms of agreement Institute will be responsible for biological evaluation and further development of discovered inhibitors.
About Quantum Pharmaceuticals.
Quantum Pharmaceuticals is a drug discovery company based in Moscow, Russia specializing in small molecule screening and design through the use of its proprietary technology platform.
